CCR10 and breast carcinoma: The incidence of breast carcinoma metastasized to chest wall cutaneous is 23.9%.[9] Histologically, the skin metastasis in breast cancer may be related to CCR10 and its skin-specific ligand CCL27/CTACK.[10] The method most commonly used at the metastatic chest wall cutaneous involvement in breast cancer remains systemic chemotherapy.